---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-088068"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2026-08-12T12:30:30+00:00"
generated_at: "2026-08-12T12:35:10.046609+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Citius Oncology appoints Jonathan Peri as independent director, board expands to nine

## Summary
- Board expanded to nine members; Peri appointed as Class I director effective Aug 10, 2026.
- Peri is President of Manor College, former VP/GC of Neumann University, and lead advisory director of First State Bank.
- Board determined Peri independent under Nasdaq rules; majority of board remains independent.
- Peri will be compensated per company's independent director program, currently under review.
- No transactions requiring disclosure under Item 404(a) involving Peri were reported.

## SEC filing metadata
- accession: 0001213900-26-088068
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2026-08-12T12:30:30+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000121390026088068/0001213900-26-088068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000121390026088068/ea0301456-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-088068
- JSON: https://secwatch.observer/filing/0001213900-26-088068.json
- Plain text: https://secwatch.observer/filing/0001213900-26-088068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.